Michael Rosenzweig
Seminars
Thursday 2nd January 2025
In Vivo Induction of CD19 CAR-T Cells using mRNA as a Therapeutic for Autoimmune Indications
12:15 pm
- Describing Capstan’s LNP platform capable of extra-hepatic delivery
- Targeting the hematopoietic system with tolerable doses of mRNA-LNP
- Discussing the pre-clinical CAR-T data in mouse and NHPs using Capstan’s technology
